Please provide your email address to receive an email when new articles are posted on . Synapse Biomedical has received premarket approval from the FDA for its NeuRx Diaphragm Pacing System, which ...
Avery Biomedical Devices, a manufacturer in Commack, is changing the lives of people around the world with its industry-leading technology: the diaphragm pacemaker. The company’s Avery Breathing ...
The U.S. Food and Drug Administration recently announced that it approved the NeuRx DPS RA/4 Respiratory Stimulation System, an implantable electronic device that stimulates the diaphragm and allows ...
October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic ...
Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
More than a decade after it first became available to help patients hospitalized with spinal cord injuries breathe more naturally than they can with a ventilator, Synapse Biomedical’s diaphragm pacing ...
OBERLIN, Ohio, April 5, 2023 /PRNewswire/ -- Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx ® Diaphragm Pacing System (NeuRx DPS ®) for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results